Stockscreener 앱 받기
7.53
6.51%
0.46
전일 마감가:
$7.07
열려 있는:
$6.98
하루 거래량:
2.96M
Relative Volume:
2.62
시가총액:
$719.18M
수익:
$1,000.00K
순이익/손실:
$-48.81M
주가수익비율:
-9.7325
EPS:
-0.7737
순현금흐름:
$-39.95M
1주 성능:
+13.40%
1개월 성능:
+58.86%
6개월 성능:
+62.28%
1년 성능:
+910.74%
1일 변동 폭
$6.91
$7.64
1주일 범위
$6.06
$7.64
52주 변동 폭
$0.712
$8.33
셰턱랩스 Stock (STTK) Company Profile
명칭
Shattuck Labs Inc
전화
512-900-4690
주소
500 W. 5TH STREET, AUSTIN
Compare STTK vs VRTX, REGN, ARGX, RVMD, ALNY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
7.53 | 675.24M | 1,000.00K | -48.81M | -39.95M | -0.7737 |
VRTX
Vertex Pharmaceuticals Inc
|
485.65 | 123.36B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.69 | 71.18B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
860.55 | 53.68B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
186.16 | 38.09B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
267.47 | 37.80B | 4.29B | 577.22M | 641.34M | 4.2086 |
셰턱랩스 Stock (STTK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2026-03-06 | 재개 | Needham | Buy |
| 2026-01-28 | 개시 | Piper Sandler | Overweight |
| 2025-12-01 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-09-08 | 개시 | Wedbush | Outperform |
| 2025-03-17 | 개시 | Leerink Partners | Outperform |
| 2024-10-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-10-02 | 다운그레이드 | Needham | Buy → Hold |
| 2024-10-01 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-06-17 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-08-31 | 개시 | BTIG Research | Buy |
| 2022-06-01 | 개시 | Citigroup | Buy |
| 2022-05-02 | 개시 | H.C. Wainwright | Buy |
| 2021-04-14 | 개시 | Berenberg | Buy |
| 2021-01-11 | 개시 | Evercore ISI | Outperform |
| 2020-11-03 | 개시 | Citigroup | Buy |
| 2020-11-03 | 개시 | Cowen | Outperform |
| 2020-11-03 | 개시 | Needham | Buy |
모두보기
셰턱랩스 주식(STTK)의 최신 뉴스
Form 13D/A Shattuck Labs For: 17 July By Investing.com - Investing.com Nigeria
Redmile updates 9.9% Shattuck Labs (STTK) stake after July trades - Stock Titan
Shattuck Labs, Inc. (STTK) Discusses Phase I Results for DR3 Blocking Antibody SL-325 and Pipeline UpdateSlideshow (NASDAQ:STTK) 2026-07-08 - Seeking Alpha
Shattuck Labs CTO Abhinav Shukla sells $2,874 in company stock By Investing.com - Investing.com Nigeria
Shattuck Labs CTO Abhinav Shukla sells $2,874 in company stock - Investing.com
Form 4 Shattuck Labs Inc For: 7 July By Investing.com - Investing.com Nigeria
Shattuck Labs (STTK) CTO exercises options and makes small 10b5-1 sale - Stock Titan
Shattuck Labs outlines its oncology platform as investors assess long-term prospects - ad-hoc-news.de
STTKShattuck Labs Inc Options - Finviz
Shattuck Labs focuses on immunotherapy pipeline as investors watch clinical milestones - ad-hoc-news.de
Insider Sell: Arundathy Pandite Sells 30,000 Shares of Shattuck Labs Inc (STTK) - GuruFocus
Shattuck Labs cmo Pandite sells $210,300 in company stock - Investing.com UK
Abhinav Shukla, Shattuck Labs CTO, sells $166,131 in stock By Investing.com - Investing.com South Africa
Form 4 Shattuck Labs Inc For: 2 July By Investing.com - Investing.com Canada
Shattuck Labs cmo Pandite sells $210,300 in company stock By Investing.com - Investing.com Australia
Abhinav Shukla, Shattuck Labs CTO, sells $166,131 in stock - Investing.com
Shattuck Labs (NASDAQ: STTK) CTO option exercises and 23,465-share sale disclosed - Stock Titan
Shattuck Labs (STTK) CMO sells 30,000 shares under 10b5-1 plan - Stock Titan
Form 144 Shattuck Labs For: 2 July By Investing.com - Investing.com Nigeria
410-share sale reported by STTK insider (NASDAQ: STTK) via option exercise - Stock Titan
Form 144 Shattuck Labs For: 1 July By Investing.com - Investing.com South Africa
Abhinav A. Shukla (STTK) files to sell 100 common shares via Form 144 - Stock Titan
Form 144 Shattuck Labs For: 30 June By Investing.com - Investing.com Nigeria
STTK (NASDAQ) files Rule 144 notice for stock-option sale on 06/30/2026 - Stock Titan
Shattuck Labs, Inc.(NasdaqGS:STTK) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Shattuck Labs, Inc.(NasdaqGS: STTK) added to Russell 2500 Growth Benchmark - marketscreener.com
Shattuck Labs, Inc.(NasdaqGS: STTK) added to Russell 2000 Index - marketscreener.com
Shattuck Labs, Inc.(NasdaqGS: STTK) added to Russell 2000 Value Benchmark - marketscreener.com
Shattuck Labs, Inc.(NasdaqGS: STTK) added to Russell Microcap Value Benchmark Index - marketscreener.com
Shattuck Labs, Inc.(NasdaqGS: STTK) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Shattuck Labs, Inc.(NasdaqGS: STTK) added to Russell 2000 Growth Benchmark - marketscreener.com
Shattuck Labs, Inc.(NasdaqGS: STTK) added to Russell 3000E Growth Benchmark - marketscreener.com
Shattuck Labs, Inc.(NasdaqGS: STTK) added to Russell Microcap Index - marketscreener.com
Shattuck Labs, Inc. Actuals & Estimates (NASDAQ:STTK) - TradingView
Price to sales forward of Shattuck Labs, Inc. – NASDAQ:STTK - TradingView
Enterprise value to EBIT forward of Shattuck Labs, Inc. – NASDAQ:STTK - TradingView
Price to book forward of Shattuck Labs, Inc. – NASDAQ:STTK - TradingView
Shattuck Labs Inc (STTK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Price to earnings forward of Shattuck Labs, Inc. – NASDAQ:STTK - TradingView
STTK Forecast — Price Target — Prediction for 2027 - TradingView
Shattuck Labs (STTK) Edges Higher as Biotech Sentiment ImprovesUndervalued Stocks - dars.gov.et
STTK Q1 2026 Earnings: Narrower Loss Beats Estimates; Shares RiseROIC Trend Report - dars.gov.et
Shattuck Labs Inc (STTK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Shattuck Labs drops 6%, prices $75M share raise at $4 per share - MSN
Citi Upgrades Shattuck Labs(STTK.US) to Buy Rating, Maintains Target Price $7 - Moomoo
셰턱랩스 (STTK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
셰턱랩스 주식 (STTK) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Shukla Abhinav A. | Chief Technical Officer |
Jul 02 '26 |
Option Exercise |
3.57 |
410 |
1,464 |
86,790 |
| Shukla Abhinav A. | Chief Technical Officer |
Jul 02 '26 |
Sale |
7.01 |
410 |
2,874 |
86,380 |
| Shukla Abhinav A. | Chief Technical Officer |
Jun 30 '26 |
Option Exercise |
3.57 |
23,365 |
83,413 |
109,745 |
| Shukla Abhinav A. | Chief Technical Officer |
Jul 01 '26 |
Option Exercise |
3.57 |
100 |
357 |
86,480 |
| Shukla Abhinav A. | Chief Technical Officer |
Jun 30 '26 |
Sale |
7.08 |
23,365 |
165,424 |
86,380 |
| Shukla Abhinav A. | Chief Technical Officer |
Jul 01 '26 |
Sale |
7.07 |
100 |
707 |
86,380 |
| Pandite Arundathy N. | Chief Medical Officer |
Jun 30 '26 |
Sale |
7.01 |
30,000 |
210,300 |
136,219 |
0.80%
2.11%
자본화:
|
볼륨(24시간):